COMPOUNDS THAT DEGRADE AND TARGETE MALE HORMONE RECEPTORS AND MEDICINES CONTAINING THESE COMPOUNDS

VN10061457BActive Publication Date: 2026-10-01ARVINAS OPERATIONS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202204460
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2020-12-18
Publication Date: 2026-10-01
Estimated Expiration: 2040-12-18

Application Information

Patent Timeline

18 Dec 2020

Application

VN1202204460

01 Oct 2026

Publication

VN10061457B

Inventors: CREW, Andrew P.; DONG, Hanqing

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention involves the synthesis and preparation of compounds. These compounds are used in the treatment of prostate cancer, including metastatic and / or refractory prostate cancer, in patients requiring treatment.

Need to check novelty before this filing date? Find Prior Art